Clinical characteristics of patients with resistant hypertension: the RESIST-POL study

[1]  J. Floras,et al.  Sleep Apnea and Cardiovascular Disease: A Bidirectional Relationship , 2012, Circulation.

[2]  D. Calhoun,et al.  Resistant hypertension, obstructive sleep apnoea and aldosterone , 2012, Journal of Human Hypertension.

[3]  D. Calhoun,et al.  Resistant hypertension: incidence, prevalence, and prognosis. , 2012, Circulation.

[4]  Heather M. Tavel,et al.  Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients , 2012, Circulation.

[5]  Deepak L. Bhatt,et al.  Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. , 2012, European heart journal.

[6]  S. Oparil,et al.  Refractory Hypertension: Definition, Prevalence, and Patient Characteristics , 2012, Journal of clinical hypertension.

[7]  T. Douglas Bradley,et al.  Obstructive Sleep Apnea: The Most Common Secondary Cause of Hypertension Associated With Resistant Hypertension , 2011, Hypertension.

[8]  B. Egan,et al.  Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008 , 2011, Circulation.

[9]  J. Banegas,et al.  Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring , 2011, Hypertension.

[10]  D. Calhoun,et al.  Aldosteronism and Resistant Hypertension , 2011, International journal of hypertension.

[11]  Alexander G Logan,et al.  Relationship Between Overnight Rostral Fluid Shift and Obstructive Sleep Apnea in Drug-Resistant Hypertension , 2010, Hypertension.

[12]  P. Lloberes,et al.  Obstructive sleep apnoea and 24‐h blood pressure in patients with resistant hypertension , 2010, Journal of sleep research.

[13]  B. Thombs,et al.  The association of depression with adherence to antihypertensive medications: a systematic review , 2010, Journal of hypertension.

[14]  S. Oparil,et al.  Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. , 2010, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[15]  V. Montori,et al.  Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis , 2010, International Journal of Obesity.

[16]  J. Beutler,et al.  The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review , 2009, Journal of hypertension.

[17]  F. Beuschlein,et al.  Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  W. Elliott,et al.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study , 2009 .

[19]  T. Young,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[20]  D. Goff,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[21]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[22]  G. Umpierrez,et al.  Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension , 2008, Diabetes Care.

[23]  D. Rizzoni,et al.  Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma , 2007, Hypertension.

[24]  Renata Cifkova,et al.  Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .

[25]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[26]  A. Tischler,et al.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[27]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[28]  D. Calhoun,et al.  Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. , 2005, American journal of hypertension.

[29]  P. Calverley,et al.  Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. , 2004, European heart journal.

[30]  V. Somers,et al.  Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. , 2004, European heart journal.

[31]  Adelaide M. Arruda-Olson,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[32]  D. Calhoun,et al.  Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension , 2002, Hypertension.

[33]  Daniel J Buysse,et al.  Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research , 2000 .

[34]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[35]  J. Stradling,et al.  The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. , 1990, The European respiratory journal.

[36]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[37]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[38]  W. Elliott.  Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008 , 2012 .

[39]  W. Elliott.  Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk , 2012 .

[40]  Stanowisko Ptnt,et al.  [Indications for imaging and percutaneous angioplasty of renal artery stenosis in patients with arterial hypertension. Statement of the Polish Society of Hypertension, Polish Society of Nephrology and Polish Cardiac Society]. , 2010, Kardiologia polska.

[41]  M. Castanheira,et al.  Prevalence and Antimicrobial Susceptibility Profile of ESBL- and KPC-producing Enterobacteriaceae in the United States (2003 − 2008) , 2010 .

[42]  W. Elliott.  Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline , 2009 .

[43]  A. Rechtschaffen,et al.  A manual of standardized terminology, technique and scoring system for sleep stages of human subjects , 1968 .